Showing 9 articles for
Epidiolex

What’s Next For Epidiolex Maker GW Pharmaceuticals

Leafly spoke with VP Stephen Schultz about the significance of FDA approval, when Epidiolex might become available to patients, and what’s coming next from the drugmaker.

Why June 2018 Will Go Down as the Month Prohibition Crumbled

Canada, Oklahoma, and the FDA: Here's how each delivered a mortal blow to cannabis prohibition this month.

Is CBD Oil Legal Now? With Epidiolex Approved, It’s Still Not Clear

The FDA just approved the CBD drug Epidiolex. Here's what that means for the legal status of CBD oil nationwide.

FDA Approves Epidiolex, a Marijuana-Based CBD Drug for Seizures

The Food and Drug Administration approved Epidiolex to treat two rare forms of epilepsy that begin in childhood. But it's not quite medical marijuana.

Is FDA-Approved Cannabidiol a Blessing or Curse?

As the marijuana molecule cannabidiol nears FDA-approval, parents who for years have used cannabis to treat severe forms of epilepsy in their children are feeling more cautious than celebratory.

Study Finds CBD Drug Epidiolex Reduces Seizures by 42%

High daily doses of CBD significantly reduced seizures in patients with Lennox-Gastaut syndrome.

GW Pharma Responds: ‘Not Creating a Monopoly’

The pharmaceutical developer says it's pioneering markets, not elbowing out competitors.

Leafly Exclusive: GW Pharma is Moving CBD Bills on the Down Low

The proposed state measures would give the British pharma company's new drug--but not other CBD products--legal status.

The Shake: Denver Has Growhouse Brokers, and Miami Cops Bust Man with Majestic Half-Beard

Legalization advocates are at the White House today, a Utah study shows further potential for cannabis epilepsy treatment, and seriously, this guy's beard.